Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VVN001 Ophthalmic Solution for Moderate to Severe Dry Eye
CTR20211530Phase 2Completed
- Sponsor
- VivaVision Biotech
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of VVN001 in dry eye syndrome (DED), sponsored by VivaVision Biotech. Started Jul 2021; status: completed.
02
Drugs
VVN001
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on CTR20211530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211530.